Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 6, 2010, Pages 945-951

  Sam, Soya Sisy ^a   Thomas, Vinod ^a   Reddy, K S ^a   Surianarayanan, Gopalakrishnan ^a   Chandrasekaran, Adithan ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CYP1A1 MspI; Gene environment interaction; GSTM1; GSTT1; South Indian population; Upper aerodigestive tract cancers

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1;

ARTICLE; CASE CONTROL STUDY; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; HUMAN; INDIA; MALE; MIDDLE AGED; RISK; RISK ASSESSMENT; RISK FACTOR; SMOKELESS TOBACCO; SMOKING;

CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS;

EID: 77951636310     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-009-0738-6     Document Type: Article

References (40)

1. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB (2007) Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28:1455-1462
2. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3-28
3. Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G (1990) Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 48:357-369
4. Boccia S, Cadoni G, Sayed-Tabatabaei FA, Volante M, Arzani D, De Lauretis A et al (2008) CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134:93-100
5. Cha IH, Park JY, Chung WY, Choi MA, Kim HJ, Park KK (2007) Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J 48:233-239
6. Consolidated Report of the Hospital Based Cancer Registries: 2001-2003 (2004) National Cancer Registry Programme, Indian Council of Medical Research, New Delhi
7. Frank SA (2004) Genetic predisposition to cancer-insights from population genetics. Nat Rev Genet 5:764-772
8. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574:112-123
9. Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J et al (2006) Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 28:819-826
10. Gronau S, Koenig-Greger D, Jerg M, Riechelmann H (2003) Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otolaryngol Head Neck Surg 128:674-680
11. Hawkins RJ, Wang EE, Leake JL (1999) Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care. J Can Dent Assoc 65:617-628
12. Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600
13. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51-88
14. Heagerty AH, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA et al (1994) Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 343:266-268
15. Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML et al (2003) CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 24:875-882
16. Hung RJ, van der OH, Tavtigian SV, Brennan P, Boffetta P, Hashibe M (2005) Perspectives on the molecular epidemiology of aerodigestive tract cancers. Mutat Res 592:102-118
17. Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biorklund A et al (1998) Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82:1367-1375
18. Mehrotra R, Singh M, Gupta RK, Singh M, Kapoor AK (2005) Trends of prevalence and pathological spectrum of head and neck cancers in North India. Indian J Cancer 42:89-93
19. Mishra DK, Kumar A, Srivastava DS, Mittal RD (2004) Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population Asian Pac. J Cancer Prev 5:362-365
20. Mudur G (2005) India has some of the highest cancer rates in the world. BMJ 330:215
21. Nair UJ, Nair J, Mathew B, Bartsch H (1999) Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 20:743-748
22. Parkin DM, Whelan SL, Ferlay J, Raymond LA, Woung J (1997) Cancer incidence in five continents. vol. VII. IARC, Lyon: IARC Scientific Publications; No. 143.
23. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM et al (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276
24. Roy B, Sikdar N (2003) Polymorphisms in drug-metabolizing genes and risk of head and neck squamous cell carcinoma. Int J Hum Genet 3:99-108
25. Sam SS, Thomas V, Reddy KS, Surianarayanan G, Chandrasekaran A (2008) CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. Head Neck 30:1566-1574
26. Sanderson RJ, Ironside JA (2002) Squamous cell carcinomas of the head and neck. BMJ 315:822-827
27. Sato M, Sato T, Izumo T, Amagasa T (1999) Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 20:1927-1931
28. Schwarz D, Kisselev P, Cascorbi I, Schunck WH, Roots I (2001) Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7, 8-dihydrodiol by human CYP1A1 variants. Carcinogenesis 22:453-459
29. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 266:1-9
30. Soya SS, Vinod T, Reddy KS, Gopalakrishnan S, Adithan C (2007) Genetic polymorphism of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to upper aerodigestive tract cancers in a south Indian population. Eur J Cancer 43:2698-2706
31. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618-627
32. Tamil Nation [home page on the internet]: a trans state nation: Tamil Diaspora. Available from URL: http://www.tamilnation.org/search.htm. Accessed 24 March 2009
33. Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T (1999) Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 35:191-196
34. Taningher M, Malacarne D, Izzotti A, Ugolini D, Parodi S (1999) Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 436:227-261
35. Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y et al (2003) Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int J Hyg Environ Health 206:149-171
36. Thomas G, Hashibe M, Jacob BJ, Ramadas K, Mathew B, Sankaranarayanan R et al (2003) Risk factors for multiple oral premalignant lesions. Int J Cancer 107:285-291
37. Townsend D, Tew K (2003) Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am J Pharmacogenomics 3:157-172
38. Varela-Lema L, Taioli E, Ruano-Ravina A, Barros-Dios JM, Anantharaman D, Benhamou S (2008) Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med 10:369-384
39. Vaury C, Lainé R, Noguiez P, de Coppet P, Jaulin C, Praz F et al (1995) Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res 55:5520-5523
40. Vondracek M, Xi Z, Larsson P, Baker V, Mace K, Pfeifer A et al (2001) Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 22:481-488